1. ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
   Zhendong Liu et al, 2021, Frontiers in Genetics CrossRef
2. HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma
   Qi Yao et al, 2022, Journal of Oncology CrossRef
3. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor
   Sintawat Wangsiricharoen et al, 2024, Modern Pathology CrossRef
4. Expression of Potential Antibody–Drug Conjugate Targets in Cervical Cancer
   Michael R. Mallmann et al, 2024, Cancers CrossRef
5. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma
   Fatih Yalcin et al, 2024, Acta Neuropathologica Communications CrossRef
6. GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma—Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis
   Yohei Kawasaki et al, 2022, Pathology and Oncology Research CrossRef
7. Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
   Zhiying Lin et al, 2022, Cancer Cell International CrossRef
8. Concurrent Activation of Both Survival-Promoting and Death-Inducing Signaling by Chloroquine in Glioblastoma Stem Cells: Implications for Potential Risks and Benefits of Using Chloroquine as Radiosensitizer
   Andreas Müller et al, 2023, Cells CrossRef
9. GPNMB: a potent inducer of immunosuppression in cancer
   Anna-Maria Lazaratos et al, 2022, Oncogene CrossRef
10. Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation
    Xiao Feng et al, 2023, Journal of Neuro-Oncology CrossRef